Neuropathic pain is a form of chronic pain with a prevalence ranging from 7-10% of the population in developed countries. The most commonly used pharmaceutical drug in the treatment of neuropathic pain is an antidepressant. Some herbs such as nutmeg (Myristica fragrans), cloves (Syzygium aromaticum), and ginger (Zingiber officinale) empirically can be used as herbal medicine to reduce nerve tension with lower side effects. The ingredients that have been obtained will be extracted to get herbal extracts, then produced to get herbal drinks that can easily be consumed by most of the consumers. This study examines the techno-economic analysis of a healthy herbal drink that provides the cure for pain and can also address people who love healthy drinks. The formulation of the herbal drinks consists of cloves, nutmeg, and ginger. The manufacturing process consists of the extraction of cloves, nutmeg, and ginger in hot water and then filtration before being sealed in a bottle. The plant design will produce 4,133 bottles per day with a price of Rp 15,000 for each bottle. The capital investment of our plant is Rp 10,821,420,278, with an IRR as high as 122.06%. Our NPV is Rp 113,277,031,973 with payback period of 1.14 years. Our product is relatively sensitive to the selling price and the price of the raw materials.
Skip Nav Destination
,
,
Article navigation
16 August 2022
THE 6TH BIOMEDICAL ENGINEERING’S RECENT PROGRESS IN BIOMATERIALS, DRUGS DEVELOPMENT, AND MEDICAL DEVICES: Proceedings of the 6th International Symposium of Biomedical Engineering (ISBE) 2021
7–8 July 2021
Depok, Indonesia
Research Article|
August 16 2022
Techno-economic analysis of Indonesian anti-neurodegenerative mixed-herb extract manufacturing plant Available to Purchase
Dewi Tristantini;
Dewi Tristantini
a)
1
Department of Chemical Engineering, Faculty of Engineering, Universitas Indonesia
, Kampus UI Depok, West Java 16424 Indonesia
a)Corresponding author: [email protected]
Search for other works by this author on:
David Lazuardi;
David Lazuardi
b)
1
Department of Chemical Engineering, Faculty of Engineering, Universitas Indonesia
, Kampus UI Depok, West Java 16424 Indonesia
Search for other works by this author on:
Leon Lukhas Santoso
Leon Lukhas Santoso
c)
1
Department of Chemical Engineering, Faculty of Engineering, Universitas Indonesia
, Kampus UI Depok, West Java 16424 Indonesia
Search for other works by this author on:
Dewi Tristantini
1,a)
David Lazuardi
1,b)
Leon Lukhas Santoso
1,c)
1
Department of Chemical Engineering, Faculty of Engineering, Universitas Indonesia
, Kampus UI Depok, West Java 16424 Indonesia
AIP Conf. Proc. 2537, 040004 (2022)
Citation
Dewi Tristantini, David Lazuardi, Leon Lukhas Santoso; Techno-economic analysis of Indonesian anti-neurodegenerative mixed-herb extract manufacturing plant. AIP Conf. Proc. 16 August 2022; 2537 (1): 040004. https://doi.org/10.1063/5.0097887
Download citation file:
Pay-Per-View Access
$40.00
Sign In
You could not be signed in. Please check your credentials and make sure you have an active account and try again.
37
Views
Citing articles via
The implementation of reflective assessment using Gibbs’ reflective cycle in assessing students’ writing skill
Lala Nurlatifah, Pupung Purnawarman, et al.
Effect of coupling agent type on the self-cleaning and anti-reflective behaviour of advance nanocoating for PV panels application
Taha Tareq Mohammed, Hadia Kadhim Judran, et al.
Design of a 100 MW solar power plant on wetland in Bangladesh
Apu Kowsar, Sumon Chandra Debnath, et al.
Related Content
Analgesic activity of Indonesian anti-neurodegenerative mixed-herb water extract
AIP Conf. Proc. (August 2022)
Immunomodulatory activity based on total protein serum from Indonesian anti-neurodegenerative mixed-herb water extract
AIP Conf. Proc. (August 2022)
Total phenolic, UPLC-QTOF-MS analysis and antidepressant-like effect in the mice forced swim test of Jamu Neuropathic Pain Reducer
AIP Conf. Proc. (December 2019)
A review on diverse herbs utilized in asthma
AIP Conf. Proc. (December 2024)
Neuropathic pain and diabetes: A complicated clinical condition
AIP Conf. Proc. (February 2024)